Skip to main content
. 2020 Jan 28;13:853–863. doi: 10.2147/OTT.S231493

Figure 1.

Figure 1

Overall survival. (A) +, ER persistent positivity; + to -, ER loss in expression; -, ER persistent negativity; - to +, ER gains in expression; (B) +, PR persistent positivity; + to -, PR loss in expression; -, PR persistent negativity; - to +, PR gains in expression; (C) Group1, HR+/HER2−/+ to HR+/HER2−/+; Group 2, HR+/HER2−/+ to HR/HER2−/+; Group 3, HR/HER2to HR/HER2; Group 4, HR/HER2−/+ to HR+/HER2−/+.